Close Menu

With $149 and a quick cheek swab, HairDX says they can tell men whether or not they will develop male-pattern baldness -- since "looking at your father's or grandfather's head has been an inaccurate, nonscientific barometer," says Peter Novak, who is on the company's scientific advisory board.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports. 

The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.

Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.

In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.